# 16. Hypercare Plan — First 30 Days — Clinical Workspace 2.0

**Version:** 1.0  
**Date:** 2026-06-26  
**Audience:** Operations, Support Lead, Clinical SME, Engineering, Product  
**Scope:** Intensive operational support during the first 30 days of controlled go-live.

---

## 1. Hypercare Objectives

1. Detect and resolve issues before they affect patient care or consent validity.
2. Build confidence among physicians, nurses, and patients.
3. Validate that operational runbook, support handover, and monitoring are effective.
4. Collect structured feedback for the next rollout phase.
5. Achieve stable operations by day 30 so hypercare can be exited.

---

## 2. Entry Criteria

- [ ] Go-live checklist complete.
- [ ] Feature flag enabled only for pilot group.
- [ ] Support team trained and roster published.
- [ ] Operational Runbook and Support Handover Guide distributed.
- [ ] Monitoring dashboards live and alert thresholds configured.
- [ ] Escalation matrix confirmed.

---

## 3. Coverage Model

| Week | Hours of Coverage | Primary Responder | Backup Responder | Required Roles |
|------|-------------------|-------------------|------------------|----------------|
| 1 (Days 1–7) | 08:00–22:00, 7 days | Support Lead | Tier 2 engineer | Support, Engineering, Clinical SME, DevOps |
| 2 (Days 8–14) | 08:00–20:00, 7 days | Tier 2 support | Tier 2 engineer | Support, Engineering, Clinical SME |
| 3 (Days 15–21) | 08:00–18:00, business days | Tier 2 support | Engineering on-call | Support, Engineering |
| 4 (Days 22–30) | Business hours | Tier 1 support | Tier 2 support | Support |

Adjust coverage based on incident volume and pilot site needs.

---

## 4. Daily Hypercare Cadence

### Day 1–7: Intensive

| Time | Activity | Owner | Output |
|------|----------|-------|--------|
| 08:00 | Shift handover and open-ticket review | Outgoing / incoming leads | Handover note |
| 09:00 | Hypercare standup (15 min) | Support Lead | Action list |
| 11:00 | First-patient-through check | Clinical SME | Feedback note |
| 14:00 | Midday metrics and incident review | Operations | Status update |
| 18:00 | Evening handover | Support Lead | Handover note |
| 22:00 | End-of-day summary to stakeholders | Support Lead | EOD report |

### Day 8–30: Stabilizing

| Time | Activity | Owner | Output |
|------|----------|-------|--------|
| 09:00 | Daily standup | Support Lead | Action list |
| 14:00 | Metrics and issue review | Operations | Status update |
| 17:00 | End-of-day summary | Support Lead | EOD report |

---

## 5. Key Metrics and Targets

| Metric | Target | Review Frequency |
|--------|--------|------------------|
| Workspace availability | ≥ 99.5% | Daily |
| Package resolution time (p95) | ≤ 500 ms | Daily |
| Consent dispatch success rate | ≥ 98% | Daily |
| Patient completion rate | ≥ 85% | Daily |
| Signature capture success rate | ≥ 98% | Daily |
| Support ticket volume | Trend downward by week 3 | Weekly |
| Average ticket resolution time | ≤ 4 hours (Tier 1/2) | Weekly |
| Open P0/P1 defects | 0 | Daily |
| User satisfaction score (pilot) | ≥ 4.0 / 5 | Weekly |

---

## 6. Daily Checklist

- [ ] Review monitoring dashboards for anomalies.
- [ ] Review all new support tickets and assign owners.
- [ ] Confirm no active SEV-1/SEV-2 incidents.
- [ ] Validate at least one end-to-end consent journey.
- [ ] Check feature flag state and rollout group membership.
- [ ] Update Known Issues Register with any new findings.
- [ ] Capture user feedback from at least one physician and one nurse.
- [ ] Send end-of-day status report to stakeholders.

---

## 7. Issue Triage and Escalation

| Severity | Response Time | Resolution Target | Escalation |
|----------|---------------|-------------------|------------|
| SEV-1 | 15 minutes | 2 hours | Immediate executive / engineering escalation |
| SEV-2 | 1 hour | 4 hours | Engineering Lead / Clinical SME |
| SEV-3 | 4 hours | 24 hours | Tier 2 lead |
| SEV-4 | Next business day | 72 hours | Tier 1 supervisor |

See [14-operational-runbook.md](./14-operational-runbook.md) for full incident response details.

---

## 8. Feedback Collection

| Source | Method | Frequency | Owner |
|--------|--------|-----------|-------|
| Physicians | Short survey + optional interview | Weekly | Clinical SME |
| Nurses / support | Short survey + standup input | Weekly | Support Lead |
| Patients | Optional on-screen rating or paper form | Daily (first week), then weekly | Compliance |
| Compliance / QA | Evidence sample review | Weekly | Compliance / QA |

---

## 9. Weekly Review Meeting

**Attendees:** Support Lead, Operations, Clinical SME, Engineering Lead, Product, Compliance (as needed).

**Agenda:**
1. Metrics review against targets.
2. Incident and defect summary.
3. Open risks and known issues.
4. User feedback themes.
5. Decisions on scope changes, additional training, or rollback.
6. Action items for the next week.

---

## 10. Exit Criteria (End of Day 30)

- [ ] No open SEV-1/SEV-2 incidents for 7 consecutive days.
- [ ] All P0/P1 defects closed or accepted as observations.
- [ ] Support ticket volume and resolution time within normal operations thresholds.
- [ ] Key metrics stable at target levels for 7 consecutive days.
- [ ] Operational Runbook and Support Handover Guide updated with lessons learned.
- [ ] Known Issues Register and Open Risks Register reviewed and accepted.
- [ ] Stakeholder sign-off for hypercare exit obtained.

---

## 11. Hypercare Exit Report Template

| Section | Content |
|---------|---------|
| Summary | Hypercare period, sites, users, and volume |
| Metrics | Availability, resolution time, completion rate, ticket volume |
| Incidents | List of SEV-1/2/3 incidents, root cause, resolution |
| Defects | P0/P1 defects closed or accepted |
| Feedback | Themes from physicians, nurses, patients |
| Risks | Open risks accepted for normal operations |
| Decisions | Go / no-go for next phase |
| Attachments | Sign-off templates, updated runbook |

---

## 12. Sign-Off

| Role | Name | Signature | Date |
|------|------|-----------|------|
| Operations | | | |
| Support Lead | | | |
| Clinical SME | | | |
| Engineering Lead | | | |
| Executive Sponsor | | | |

---

**Related documents:** [14-operational-runbook.md](./14-operational-runbook.md), [15-support-handover-guide.md](./15-support-handover-guide.md), [11-go-live-checklist.md](./11-go-live-checklist.md), [18-open-risks-register.md](./18-open-risks-register.md).
